Tobacco Use Has ‘Direct Impact’ on Risk for Chronic Rhinosinusitis
The correlation between tobacco use and chronic rhinosinusitis was observed in both males and...
Read MoreJan 9, 2023
The correlation between tobacco use and chronic rhinosinusitis was observed in both males and...
Read MoreJan 6, 2023
Despite preventive procedures and treatment for deep sternal wound infections, incidence and...
Read MoreJan 4, 2023
Iron deficiency is a significant comorbidity of heart failure (HF), defined as the inability of...
Read MoreJan 4, 2023
In patients with heart failure (HF), iron deficiency (ID) is a well-recognized therapeutic target;...
Read MoreJan 4, 2023
“I would be a lot healthier if you’d stop finding things wrong with me!”
Read MoreDec 26, 2022
Findings that show COVID-19 vaccination during pregnancy improves neonatal outcomes can serve “a...
Read MoreDec 23, 2022
RSV was associated with significant morbidity among children and adults, and clinicians ‘should...
Read MoreDec 22, 2022
“Heads, fat is bad and carbs are good. Tails, fat is good and carbs are bad.”
Read MoreDec 21, 2022
Patients with chronic lymphocytic leukemia (CLL) infected with COVID-19 during the most recent...
Read MoreDec 21, 2022
The ACR 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly.
Read MoreDec 21, 2022
“The good news, it’s OK to eat butter after all. The bad news, it’s not OK to...
Read MoreDec 20, 2022
A single assessment of the circulating tumor cells (CTC) count before treatment can guide the...
Read MoreDec 20, 2022
In vitro studies using DNA barcoded cell lines demonstrated that resistance to CDK4/6 inhibitors...
Read MoreDec 20, 2022
Among patients with HR-positive/HER2-negative metastatic breast cancer, combining palbociclib with...
Read MoreDec 20, 2022
Duration of first-line CDK4/6 inhibitor therapy in patients with ER-positive/HER2-negative...
Read MoreDec 20, 2022
Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response...
Read MoreDec 20, 2022
In women carrying a germline pathogenic variant for breast cancer, like BRCA1, BRCA2, or CHEK2,...
Read MoreDec 20, 2022
Paclitaxel/cemiplimab/fianlimab is a highly effective combination for neoadjuvant therapy in both...
Read More